Protection of mammography screening against death from breast cancer in women aged 40–64 years
- 174 Downloads
This study assessed the efficacy of community-based screening mammography in protecting against breast cancer death, asking whether age differences in efficacy persisted in the 1990s.
In a case–control study with follow-up, odds ratios (OR) were used to estimate the relative mortality rates from invasive breast cancer among women with at least one screening mammogram in the two years prior to a baseline reference date compared to non-screened women, adjusting for potential confounding. The multicenter population-based study included 553 black and white women diagnosed during 1994–1998 who died in the following five years, and 4016 controls without breast cancer.
Efficacy for reducing the rate of breast cancer death within five years after diagnosis was greater at ages 50–64 years (OR = 0.47, 95% confidence interval (CI) 0.35–0.63) than at ages 40–49 (OR = 0.89, 95% CI 0.65–1.23), and greater among postmenopausal (OR = 0.45, 95% CI 0.33–0.62) than premenopausal women (OR = 0.74, 95% CI 0.53–1.04). Estimates of efficacy were conservative, as shown by sensitivity analyses addressing whether cancer was discovered by a screening mammogram, age at which screening was received, the length of the screening observation window, and years of follow-up after diagnosis.
Despite the persistence of age differences in efficacy of mammography screening, with greater observed benefit for women aged 50–64 years, these findings support current screening recommendations for women 40–64 years old.
KeywordsMass screening Mammography Breast neoplasms Breast cancer mortality Age groups Premenopause Postmenopause
- 3.U. S. Department of Health and Human Services (2002) HHS affirms value of mammography for detecting breast cancer. Available at: http://www.hhs.gov/news/press/2002pres/20020221.html
- 4.Feig S, D’Orsi C, Hendrik R et al (1998) American College of Radiology guidelines for breast cancer screening. Am J Roentgenol 171:29–33Google Scholar
- 5.American Medical Association (2002) Report 16 of the Council on Scientific Affairs (A-99). Mammographic screening for asymptomatic women. Available at: http://www.ama-assn.org/ama/pub/category/13541.html
- 6.American College of Obstetricians and Gynecologists (2000) Primary and preventive care: periodic assessments. ACOG Committee Opinion 246. ACOG, Washington, DCGoogle Scholar
- 13.Elwood JM, Cox B, Richardson AK (1993) The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials 23:Doc No 32Google Scholar
- 16.Ries L, Eisner M, Kosary C et al (2004) SEER cancer statistics review, 1975–2001. National Cancer Institute, Bethesda, MD. Available at: http://www. seer.cancer.gov/csr/1975_2001/
- 18.Ostbye T, Taylor DJ, Yancy WJ, Krause K (2005) Associations between obesity and receipt of screening mammography, Papanicolaou tests, and influenza vaccination: results from the Health and Retirement Study (HRS) and the Asset and Health Dynamics Among the Oldest Old (AHEAD) Study. Am J Public Health 95:1623–1630PubMedCrossRefGoogle Scholar
- 19.National Center for Health Statistics (2006) Mortality data from the National Vital Statistics System. International Classification of Diseases, ninth revision (ICD-9). National Center for Health Statistics, Hyattsville, MD. Available at: http://www.cdc.gov/nchs/about/major/dvs/icd9des.htm
- 20.National Center for Health Statistics (2006) Mortality data from the National Vital Statistics System. International Classification of Diseases, tenth revision (ICD-10). National Center for Health Statistics, Hyattsville, MD. Available at: http://www.cdc.gov/nchs/about/major/dvs/icd10des.htm
- 29.American Cancer Society (2005) ACS expert disputes methodology of study questioning mammography benefit. CA Cancer J Clin 55:327–329Google Scholar
- 31.Elmore J, Weiss N, Barlow W et al (2005) Response Re: efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 97:1704–1705Google Scholar
- 33.Harris R (2005) Response Re: efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 97:1703–1704Google Scholar
- 35.Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging manual, 6th edn. Springer-Verlag, New YorkGoogle Scholar
- 36.Young JJ, Roffers S, Ries L, Fritz A, Hurlbut A (2001) SEER summary staging manual - 2000 codes and coding instructions, NIH Pub. No 01–4969. National Cancer Institute, Bethesda, MD. Available at: http://www.seer.cancer.gov/tools/ssm/
- 38.Blackman D, Bennett E, Miller D (1999) Trends in self-reported use of mammograms (1989–1997) and Papanicolaou tests (1991–1997) – Behavioral Risk Factor Surveillance System. MMWR 48:1–22Google Scholar
- 39.National Center for Health Statistics (2005) Health, United States, 2005 with chartbook on trends in the health of Americans. National Center for Health Statistics, Hyattsville, MDGoogle Scholar
- 43.Shen Y, Zelen M (2001) Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. J Clin Oncology 19:3490–3499Google Scholar